EUVIMEDEUVIMED entdecken
Open Access

Roflumilast, a phosphodiesterase-4 (PDE4) inhibitor, induces respiratory frequency plasticity that is resistant to inflammation in neonatal rat in vitro preparations

Stephen M Johnson, Jacob P Rastas, Pujal S Desai, Tracy L Baker, Jyoti J Watters

Respiratory Physiology & Neurobiology · 2025

DOI: 10.1016/j.resp.2025.104435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respiratory Physiology & Neurobiology, 2025. Verfasst von Stephen M Johnson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, United States. Electronic address…. Hauptthemen laut MEDLINE: Aminopyridines, Phosphodiesterase 4 Inhibitors, Benzamides, Inflammation. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Premature and newborn infants often have prolonged apneas and are susceptible to bacterial infections that further disrupt breathing. Phoshodiesterase-4 (PDE4) inhibitor drugs increase inspiratory motor activity and appear to induce a long-lasting increase in inspiratory frequency ("frequency plasticity"). To test whether a PDE4 inhibitor drug induces frequency plasticity, neonatal rat brainstem-spinal cords were isolated and exposed to bath-applied roflumilast (10 min, 0.02-1.0 µM). Roflumilast acutely increased burst frequency and induced frequency plasticity in a concentration-dependent manner. Blockade of protein kinase A (PKA) or exchange protein activated by cAMP (EPAC) signaling pathways abolished the induction, but not the maintenance, of roflumilast-induced frequency plasticity. Brainstem-spinal cords isolated from neonatal rats injected with lipopolysaccharide (LPS, 0.1 mg/kg, 3 h prior) expressed frequency plasticity following bath-applied roflumilast at 0.05-0.5 µM, but not at lower concentrations. This shows that roflumilast-induced frequency plasticity is largely resistant to LPS-induced inflammation. Thus, roflumilast increases inspiratory burst frequency acutely and induces frequency plasticity even during ongoing inflammation, which could have important clinical implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AminopyridinesPhosphodiesterase 4 InhibitorsBenzamidesInflammationNeuronal PlasticitySpinal CordAnimalsCyclopropanesAnimals, NewbornLipopolysaccharidesRatsRats, Sprague-DawleyDose-Response Relationship, DrugIn Vitro Techniques

Stichwörter der Autor:innen

CAMPEPACNeonatal ratPKAPhosphodiesterase inhibitorRespiratory motor control

Substanzen

RoflumilastAminopyridinesCyclopropanesPhosphodiesterase 4 InhibitorsBenzamidesLipopolysaccharides

Autor:innen und Institutionen

  • Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, United States. Electronic address: stephen.m.johnson@wisc.edu.
  • Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, United States.

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Johnson, S. M., Rastas, J. P., Desai, P. S., Baker, T. L., & Watters, J. J. (2025). Roflumilast, a phosphodiesterase-4 (PDE4) inhibitor, induces respiratory frequency plasticity that is resistant to inflammation in neonatal rat in vitro preparations. Respiratory Physiology & Neurobiology. https://doi.org/10.1016/j.resp.2025.104435

Vancouver

Johnson SM, Rastas JP, Desai PS, Baker TL, Watters JJ. Roflumilast, a phosphodiesterase-4 (PDE4) inhibitor, induces respiratory frequency plasticity that is resistant to inflammation in neonatal rat in vitro preparations. Respiratory Physiology & Neurobiology. 2025. doi:10.1016/j.resp.2025.104435

BibTeX
@article{Johnson2025,
  author = {Johnson, Stephen M and Rastas, Jacob P and Desai, Pujal S and Baker, Tracy L and Watters, Jyoti J},
  title = {Roflumilast, a phosphodiesterase-4 (PDE4) inhibitor, induces respiratory frequency plasticity that is resistant to inflammation in neonatal rat in vitro preparations},
  journal = {Respiratory Physiology & Neurobiology},
  year = {2025},
  doi = {10.1016/j.resp.2025.104435}
}
Kostenlos starten →